D'Amato Stephen J, Mealy Maureen A, Erdek Michael A, Kozachik Sharon, Smith Thomas J
From the CALMAR Pain Relief, LLC, Bonita Springs, Florida.
Johns Hopkins School of Nursing, Baltimore, Maryland.
A A Pract. 2018 Jun 15;10(12):313-315. doi: 10.1213/XAA.0000000000000695.
Central pain syndromes affect several million people worldwide. A 52-year-old woman had central pain manifest as burning pain from her left foot to the knee for 12 years after treatment for a medullary cavernoma diagnosed after a right-sided brainstem bleeding episode. All this time, her baseline pain was 5-6/10 with spikes to 9-10/10 during activity. She underwent 10 daily Scrambler (Calmare) Therapy treatments (GEOMC, Inc, Seoul, Korea) with reduction in her pain from 9-10/10 to 0-0.5/10, then 5 more sessions a month later. Her baseline pain stayed at 2/10 at 140 days with spikes only to 5/10, and no additional medications. Scrambler (Calmare) Therapy deserves further study in central pain.
中枢性疼痛综合征在全球影响着数百万人。一名52岁女性，在右侧脑干出血发作后被诊断为髓内海绵状血管瘤并接受治疗，12年来一直患有中枢性疼痛，表现为从左脚到膝盖的灼痛。在此期间，她的基线疼痛为5 - 6/10，活动时疼痛峰值可达9 - 10/10。她接受了10次每日的扰频器（Calmare）疗法治疗（韩国首尔的GEOMC公司），疼痛从9 - 10/10降至0 - 0.5/10，一个月后又进行了5次治疗。140天时，她的基线疼痛维持在2/10，疼痛峰值仅为5/10，且无需额外用药。扰频器（Calmare）疗法在中枢性疼痛方面值得进一步研究。
